UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 752

Sortiert nach

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products

Neuropsychopharmacology (New York, N.Y.), 2013-03, Vol.38 (4), p.552-562

2013

Link zum Volltext

Verfügbarkeit prüfen

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

Neuropsychopharmacology (New York, N.Y.), 2012-04, Vol.37 (5), p.1192-1203

2012

Link zum Volltext

Verfügbarkeit prüfen

N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity

Neuropsychopharmacology (New York, N.Y.), 2007-12, Vol.33 (10), p.2303-2312

2007

Link zum Volltext

Verfügbarkeit prüfen

Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil

The Journal of pharmacology and experimental therapeutics, 2009-05, Vol.329 (2), p.738

2009

Link zum Volltext

Verfügbarkeit prüfen

Salvinorin A: A Potent Naturally Occurring Nonnitrogenous κ Opioid Selective Agonist

Proceedings of the National Academy of Sciences - PNAS, 2002-09, Vol.99 (18), p.11934-11939

2002

Link zum Volltext

Verfügbarkeit prüfen

In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat

The Journal of pharmacology and experimental therapeutics, 2011-04, Vol.337 (1), p.218

2011

Link zum Volltext

Verfügbarkeit prüfen

Balance between Dopamine and Serotonin Release Modulates Behavioral Effects of Amphetamine-Type Drugs

Annals of the New York Academy of Sciences, 2006-08, Vol.1074 (1), p.245-260

2006

Link zum Volltext

Verfügbarkeit prüfen

3,4-Methylenedioxymethamphetamine (MDMA, âEcstasyâ) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro

Molecular pharmacology, 2003-06, Vol.63 (6), p.1223-1229

2003

Link zum Volltext

Verfügbarkeit prüfen

Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation

PloS one, 2013-10, Vol.8 (10), p.e77262

2013

Link zum Volltext

Verfügbarkeit prüfen

Interaction of amphetamines and related compounds at the vesicular monoamine transporter

The Journal of pharmacology and experimental therapeutics, 2006-10, Vol.319 (1), p.237

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat

Drug metabolism and disposition, 2009-11, Vol.37 (11), p.2163

2009

Link zum Volltext

Verfügbarkeit prüfen

N-Substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')

Neuropsychopharmacology (New York, N.Y.), 2005-03, Vol.30 (3), p.550-560

2005

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic and adverse actions of serotonin transporter substrates

Pharmacology & therapeutics (Oxford), 2002-07, Vol.95 (1), p.73-88

2002

Link zum Volltext

Verfügbarkeit prüfen

In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates

The Journal of pharmacology and experimental therapeutics, 2003-10, Vol.307 (1), p.138

2003

Link zum Volltext

Verfügbarkeit prüfen

Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease

The Journal of pharmacology and experimental therapeutics, 2006-08, Vol.318 (2), p.604

2006

Link zum Volltext

Verfügbarkeit prüfen

Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A

Pharmacological reviews, 2011-06, Vol.63 (2), p.316

2011

Link zum Volltext

Verfügbarkeit prüfen

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

Psychopharmacology, 2007-01, Vol.189 (4), p.407-424

2007

Link zum Volltext

Verfügbarkeit prüfen

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

Psychopharmacologia, 2007-01, Vol.189 (4), p.407-424

2007

Link zum Volltext

Verfügbarkeit prüfen

Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels

The Journal of pharmacology and experimental therapeutics, 2008-02, Vol.324 (2), p.791

2008

Link zum Volltext

Verfügbarkeit prüfen

Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates

The Journal of pharmacology and experimental therapeutics, 2013-07, Vol.346 (1), p.2

2013

Link zum Volltext

Verfügbarkeit prüfen

Monoamine transporters and psychostimulant drugs

European journal of pharmacology, 2003-10, Vol.479 (1), p.23-40

2003

Link zum Volltext

Verfügbarkeit prüfen

Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration

The Journal of pharmacology and experimental therapeutics, 2005-06, Vol.313 (3), p.1361

2005

Link zum Volltext

Verfügbarkeit prüfen

Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter

Drug and alcohol dependence, 2015-02, Vol.147, p.1-19

2015

Link zum Volltext

Verfügbarkeit prüfen

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity

Neuropsychopharmacology (New York, N.Y.), 2008-09, Vol.33 (10), p.2303-2312

2008

Link zum Volltext

Verfügbarkeit prüfen

Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension

PloS one, 2011-03, Vol.6 (3), p.e17735-e17735

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 752

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(708)
Mit Volltextzugriff
(697)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(508)
Life Sciences & Biomedicine
(474)
Animals
(289)
Humans
(266)
Male
(251)
Biological And Medical Sciences
(240)
Medical Sciences
(202)
Pharmacology & Pharmacy
(190)
Rats
(186)
Neurosciences & Neurology
(123)
Neurosciences
(119)
Female
(118)
Pharmacology. Drug Treatments
(116)
Neuropharmacology
(106)
Chemistry, Medicinal
(95)
Brain - Metabolism
(94)
Adult
(80)
Rats, Sprague-Dawley
(78)
Neurotransmitters. Neurotransmission. Receptors
(75)
Middle Aged
(72)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity

Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil

Salvinorin A: A Potent Naturally Occurring Nonnitrogenous κ Opioid Selective Agonist

In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat

Balance between Dopamine and Serotonin Release Modulates Behavioral Effects of Amphetamine-Type Drugs

3,4-Methylenedioxymethamphetamine (MDMA, âEcstasyâ) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro

Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation

Interaction of amphetamines and related compounds at the vesicular monoamine transporter

Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat

N-Substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')

Therapeutic and adverse actions of serotonin transporter substrates

In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates

Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease

Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels

Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates

Monoamine transporters and psychostimulant drugs

Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration

Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity

Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension

Suchergebnisse filtern